Glenmark inks agreement with AstraZeneca to commercialise Pulmicort Respules in Colombia
As per this agreement, AstraZeneca remains the holder of the registration for Pulmicort Respules, and will manufacture the drug.…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.